Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.

Autor: Sanyal, Arun J.1 (AUTHOR) arun.sanyal@vcuhealth.org, Ratziu, Vlad2 (AUTHOR), Loomba, Rohit3 (AUTHOR), Anstee, Quentin M.4,5 (AUTHOR), Kowdley, Kris V.6 (AUTHOR), Rinella, Mary E.7 (AUTHOR), Sheikh, Muhammad Y.8 (AUTHOR), Trotter, James F.9 (AUTHOR), Knapple, Whitfield10 (AUTHOR), Lawitz, Eric J.11 (AUTHOR), Abdelmalek, Manal F.12 (AUTHOR), Newsome, Philip N.13 (AUTHOR), Boursier, Jérôme14 (AUTHOR), Mathurin, Philippe15 (AUTHOR), Dufour, Jean-François16 (AUTHOR), Berrey, M. Michelle17 (AUTHOR), Shiff, Steven J.17 (AUTHOR), Sawhney, Sangeeta17 (AUTHOR), Capozza, Thomas17 (AUTHOR), Leyva, Rina17 (AUTHOR)
Zdroj: Journal of Hepatology. Nov2023, Vol. 79 Issue 5, p1110-1120. 11p.
Databáze: Academic Search Ultimate
Externí odkaz: